tiprankstipranks
Trending News
More News >
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
:6NQ
Germany Market

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Financial Statements

Compare
0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Financial Overview

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s market cap is currently €77.72M. The company's EPS TTM is €0.014; its P/E ratio is 75.28; Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenuezł 58.61Mzł 50.38Mzł 41.15Mzł 40.16Mzł 39.11M
Gross Profitzł 35.17Mzł 27.93Mzł 22.67Mzł 20.57Mzł 21.25M
Operating Incomezł 8.65Mzł 9.84Mzł 7.19Mzł 5.93Mzł 5.72M
EBITDAzł 14.89Mzł 15.40Mzł 13.09Mzł 10.84Mzł 11.65M
Net Incomezł 4.76Mzł 6.08Mzł 4.25Mzł 4.44Mzł 2.48M
Balance Sheet
Cash & Short-Term Investmentszł 2.17Mzł 26.77Mzł 19.46Mzł 1.84Mzł 660.00K
Total Assetszł 265.90Mzł 163.10Mzł 116.83Mzł 85.86Mzł 81.11M
Total Debtzł 70.04Mzł 15.15Mzł 6.49Mzł 13.29Mzł 9.57M
Net Debtzł 67.87Mzł -11.62Mzł -7.81Mzł 11.46Mzł 8.91M
Total Liabilitieszł 153.26Mzł 57.54Mzł 42.27Mzł 48.55Mzł 48.24M
Stockholders' Equityzł 112.64Mzł 105.56Mzł 74.55Mzł 37.31Mzł 32.87M
Cash Flow
Free Cash Flowzł -117.95Mzł -33.81Mzł -21.71Mzł -1.68Mzł 7.35M
Operating Cash Flowzł -5.34Mzł 2.95Mzł -3.28Mzł 343.00Kzł 8.16M
Investing Cash Flowzł -72.90Mzł -26.97Mzł -4.49Mzł -2.02Mzł -690.00K
Financing Cash Flowzł 53.33Mzł 36.82Mzł 20.22Mzł 2.86Mzł -6.87M
Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Earnings and Revenue History

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Debt to Assets

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis